Researchers in South Korea have revealed stunning increases in risk of cardiac, neurological and autoimmune conditions
People who received an mRNA COVID vaccine are at a 620% increased risk of myocarditis and a 175% increased risk of pericarditis, according to a new large-scale study.
Researchers in South Korea looked at health data for over nine million South Koreans, and found that those who received mRNA vaccinations for COVID were a significantly elevated risk for a variety of cardiac and neurological conditions.
As well as the significant increases in risk for myo- and pericarditis given above, individuals who received an mRNA vaccination were at 62% increased risk for Guillain-Barré syndrome, a rare neurological condition.
There was also a 16% increased risk of the most common form of lupus and a 58% risk of bullous pemphigoid, a blistering skin condition. Booster shots were associated with increased risks of autoimmune conditions such as alopecia areata (hair loss), psoriasis and rheumatoid arthritis.
The research authors noted that, because of its focus on just a single ethnic group, the study may have less validity for other ethnic groups. They also noted that the 15-month follow-up may not be long enough to capture the full range of health conditions and their onset as a result of the mRNA vaccines.
Another South Korean study recently found significant increases in the risk of Alzheimer’s disease and cognitive impairment in individuals given mRNA COVID vaccines.
